Evidence map›Paper›PMID 35875134›Full record

ArticleFrontiers in oncology2022

Clonal Evolution at First Sight: A Combined Visualization of Diverse Diagnostic Methods Improves Understanding of Leukemic Progression.

Sarah Sandmann, Yvonne Lisa Behrens, Claudia Davenport, Felicitas Thol, Michael Heuser, Daniela Dörfel, Friederike Löhr, Agnes Castrup, Doris Steinemann, Julian Varghese and 3 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Review
  3. Reconstructing Clonal Evolution-A Systematic Evaluation of Current Bioinformatics Approaches.International journal of environmental research and public health · 2023
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Sarah SandmannInstitute of Medical Informatics, University of Münster, Münster, Germany.
Yvonne Lisa BehrensDepartment of Human Genetics, Hannover Medical School, Hannover, Germany.
Claudia DavenportDepartment of Human Genetics, Hannover Medical School, Hannover, Germany.
Felicitas TholDepartment of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
Michael HeuserDepartment of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
Daniela DörfelDepartment of Hematology, Oncology and Immunology, Klinikum Region Hannover (KRH) Klinikum Siloah, Hannover, Germany.
Friederike LöhrDepartment of Hematology and Oncology, Klinikum Braunschweig, Braunschweig, Germany.
Agnes CastrupHämato-Onkologische Praxis, Hämato-Onkologische Praxis im Medicum, Bremen, Germany.
Doris SteinemannDepartment of Human Genetics, Hannover Medical School, Hannover, Germany.
Julian VargheseInstitute of Medical Informatics, University of Münster, Münster, Germany.
Brigitte SchlegelbergerDepartment of Human Genetics, Hannover Medical School, Hannover, Germany.
Martin DugasInstitute of Medical Informatics, University of Münster, Münster, Germany.
Gudrun GöhringDepartment of Human Genetics, Hannover Medical School, Hannover, Germany.
Medizinische Hochschule Hannover · DEUniversity of Münster · DEKlinikum Braunschweig · DEKlinikum Region Hannover · DEPraxis für Hämatologie und Onkologie · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Patients with myeloid neoplasia are classified by the WHO classification systems. Besides clinical and hematological criteria, cytogenetic and molecular genetic alterations highly impact treatment stratification. In routine diagnostics, a combination of methods is used to decipher different types of genetic variants. Eight patients were comprehensively analyzed using karyotyping, fluorescence

Indexed as

bioinformaticscancer cell fractionclonal evolutioncopy number variantsleukemic progressionsingle nucleotide variants

Identifiers

PMID35875134
PMCPMC9305660
OpenAlexW4284975422

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.